Home » today » News » [사회]Stagnant decline … Reinvasion possible in early December

[사회]Stagnant decline … Reinvasion possible in early December

“Possibility of a new invasion in early December … The recent increase in confirmed cases in Europe”
“Vulnerable people should receive additional doses of COVID-19 vaccine”
Improved vaccine against Omicron submutation, approved for the first time in Korea


<!– –>

[앵커]

The number of new COVID-19 patients has stopped declining and is stagnating.

In early December, the possibility of a renaissance appears and an improved vaccine for the recently dominant Omicron submutant virus will soon be introduced in Korea.

This was reported by the journalist Yoon-Jeong Shin.

[기자]

The number of new cases of COVID-19 recorded 1,040.

Although the number has decreased by about 10,000 from the previous day, the number has increased by about 2,000 from the week before, which was Hangeul Day, recording an increase from the previous week for four consecutive days.

Stopped the decline and entered a plateau,

The number of patients is not expected to decline further than now, which is an average of around 22,000 per day.

[정기석 / 코로나19 특별대응단장 : 주간 일 평균 2만 명대가 아마도 이번 겨울의 가장 바닥이 아니겠냐는 생각이 들고요. 앞으로는 조금씩 더 늘어나는 추세로 갈 것이다….]

Then, in early December, there was a chance that a real re-fashion would come back again.

This is because the number of confirmed cases has been on the rise again recently despite high vaccination rates in Europe, such as Germany and France, which showed a trend of outbreaks a month or two ahead of Korea.

The problem is that in early December only 25% of people have immunity.

[정기석 / 코로나19 특별대응단장 : 백신에 의한 것, 감염에 의한 것을 다 합쳐도 전체 인구 중에서 면역력을 갖고 있는 비율이 25%밖에 안 됩니다. 그래서 이 정도 가지고는 60세 이상을 보호할 수가 없습니다.]

Director Jeong Ki-seok urged to administer the last vaccination before August or additional vaccinations for vulnerable groups such as the elderly who were infected with Corona 19 before June.

In the midst of this, the vaccine options have become even wider.

An improved vaccine developed to address BA.5, Omicron submutation, which is the predominant species detected in over 90% of confirmed domestic cases, has been approved for emergency use.

The government decided to announce a plan to upgrade Pfizer’s bivalent vaccine later this month for people over the age of 13.

I am YTN Shin Yoon-jung.

YTN Yoonjeong Shin ([email protected])

※ ‘Your report becomes news’
[카카오톡] Search on YTN to add a channel
[전화] 02-398-8585
[메일] [email protected]

[저작권자(c) YTN 무단전재 및 재배포 금지]

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.